Have your own idea? Try our Stock Screener
U.S. Pharma Industry Analysis
UpdatedJan 28, 2025
DataAggregated Company Financials
Companies300
- 7D6.1%
- 3M-5.6%
- 1Y5.8%
- YTD3.8%
Over the last 7 days, the Pharma industry has risen 6.1%, driven by gains from Eli Lilly of 11%. This takes the industry's 12 month performance to a gain of 5.8%. Earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the U.S. Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 28 Jan 2025 | US$1.8t | US$370.4b | US$30.5b | 19x | 59.2x | 4.9x |
| Thu, 26 Dec 2024 | US$1.8t | US$369.4b | US$31.1b | 17.3x | 58.4x | 4.9x |
| Sat, 23 Nov 2024 | US$1.8t | US$373.8b | US$30.6b | 20.5x | 59.2x | 4.8x |
| Mon, 21 Oct 2024 | US$2.0t | US$365.3b | US$23.7b | 18.6x | 85.8x | 5.6x |
| Wed, 18 Sep 2024 | US$2.1t | US$364.3b | US$25.3b | 19x | 81x | 5.6x |
| Fri, 16 Aug 2024 | US$2.0t | US$362.0b | US$21.9b | 17.3x | 91.7x | 5.5x |
| Sun, 14 Jul 2024 | US$2.0t | US$357.7b | US$13.8b | 15.9x | 146.2x | 5.7x |
| Tue, 11 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 19x | 138x | 5.4x |
| Thu, 09 May 2024 | US$1.9t | US$358.2b | US$13.9b | 21x | 133.4x | 5.2x |
| Sat, 06 Apr 2024 | US$1.9t | US$355.2b | US$22.7b | 24.7x | 82x | 5.2x |
| Mon, 04 Mar 2024 | US$1.9t | US$355.3b | US$22.5b | 24.1x | 85x | 5.4x |
| Wed, 31 Jan 2024 | US$1.8t | US$351.7b | US$24.9b | 28.7x | 71.3x | 5.1x |
| Fri, 29 Dec 2023 | US$1.7t | US$375.2b | US$33.8b | 32.1x | 49.8x | 4.5x |
| Sun, 26 Nov 2023 | US$1.7t | US$375.1b | US$33.9b | 26.2x | 48.8x | 4.4x |
| Tue, 24 Oct 2023 | US$1.6t | US$382.7b | US$44.7b | 14.7x | 36.7x | 4.3x |
| Thu, 21 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 18.3x | 39.1x | 4.5x |
| Sat, 19 Aug 2023 | US$1.8t | US$381.6b | US$44.1b | 18.5x | 40.3x | 4.6x |
| Mon, 17 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.3x | 27.7x | 4.2x |
| Wed, 14 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 18.6x | 28.8x | 4.4x |
| Fri, 12 May 2023 | US$1.7t | US$395.0b | US$57.5b | 20.3x | 30.3x | 4.4x |
| Sun, 09 Apr 2023 | US$1.7t | US$401.2b | US$69.7b | 15.9x | 23.7x | 4.1x |
| Tue, 07 Mar 2023 | US$1.6t | US$401.0b | US$69.4b | 17x | 22.7x | 3.9x |
| Thu, 02 Feb 2023 | US$1.7t | US$403.0b | US$70.8b | 18x | 23.5x | 4.1x |
| Sat, 31 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.8x | 4.3x |
| Mon, 28 Nov 2022 | US$1.7t | US$403.7b | US$70.7b | 16.9x | 24.7x | 4.3x |
| Wed, 26 Oct 2022 | US$1.7t | US$403.4b | US$72.1b | 13.5x | 22.9x | 4.1x |
| Fri, 23 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 12.9x | 22x | 3.9x |
| Sun, 21 Aug 2022 | US$1.7t | US$402.8b | US$70.1b | 15.3x | 23.7x | 4.1x |
| Tue, 19 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 22x | 26.1x | 4.3x |
| Thu, 16 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20.6x | 24.3x | 4x |
| Sat, 14 May 2022 | US$1.6t | US$392.5b | US$64.4b | 20.4x | 25.3x | 4.1x |
| Mon, 11 Apr 2022 | US$1.7t | US$373.8b | US$60.7b | 22.4x | 28.5x | 4.6x |
| Wed, 09 Mar 2022 | US$1.6t | US$373.6b | US$60.3b | 19.5x | 25.7x | 4.2x |
| Fri, 04 Feb 2022 | US$1.6t | US$364.0b | US$40.7b | 21.6x | 39x | 4.4x |
Price to Earnings Ratio
39x
Current Industry PE
- Investors are optimistic on the American Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 59.2x which is higher than its 3-year average PE of 50.3x.
- The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 9.1% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | -0.046% | |
| Healthcare | 5.05% | |
| Pharma | 6.10% | |
| Pharma | 6.10% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| LLY Eli Lilly | US$808.17 | 11.4% +US$74.2b | 25.3% | PE86.9x | |
| JNJ Johnson & Johnson | US$152.89 | 4.0% +US$14.1b | -4.1% | PE26.2x | |
| BMY Bristol-Myers Squibb | US$60.60 | 7.7% +US$8.7b | 21.5% | PS2.6x | |
| ZTS Zoetis | US$173.03 | 4.3% +US$3.2b | -10.2% | PE32.1x | |
| PFE Pfizer | US$26.86 | 2.1% +US$3.2b | -2.3% | PE35.6x |
